metaPreg - Isradipine (versus exposed to other treatments) during pregnancy

Isradipine (versus exposed to other treatments)

Table Graphic exposition period:

Adverse outcome	OR 95%CI	I2	k	No. cases	No. exposed	publication bias	ROB	E-value
Maternal consequences
Assisted deliveries (forceps, vacuum, ...)	1.32 [0.33, 5.34]	-	1 study	9	39	not evaluable	ROB	-
Caesarean	0.85 [0.31, 2.30]	-	1 study	58	39	not evaluable	ROB	-
Neonatal disorders
Adverse outcome	OR 95%CI	I2	k	No. cases	No. exposed	publication bias	ROB	E-value
Low Apgar score (< 7) (at 1 min)	0.75 [0.16, 3.59]	-	1 study	7	39	not evaluable	ROB	-
Low Apgar score (< 7) (at 5 min)	1.03 [0.02, 53.02]	-	1 study		39	not evaluable	ROB	-
Neonatal hypoglycemia	0.86 [0.34, 2.15]	-	1 study	50	39	not evaluable	ROB	-
Very low Apgar score (< 5) (at 1 min)	1.03 [0.14, 7.68]	-	1 study	4	39	not evaluable	ROB	-
Hide endpoints reported in only one study ...